“…A potential solution to this problem is to develop quantitative, rapid tests around infrastructure that has already been adopted in the market at-scale. It has been previously shown that commercial glucometers can be repurposed to detect a variety of non-glucose-based targets, quantitatively measuring cocaine, Ebola, hepatitis B, foodborne pathogens, and interferon-gamma (Chen et al, 2020;Du et al, 2015;Guo et al, 2020;Lan et al, 2015Lan et al, , 2016Taebi et al, 2018;Xiang and Lu, 2011;Zhang et al, 2019Zhang et al, , 2020. There are currently 422 million people worldwide who rely on these devices daily to manage their blood sugar, making the glucometer the most prevalent piece of diagnostic equipment globally (CDC, 2020d; "Diabetes Statistics).…”